Bausch Health Companies Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Bausch Health Companies Inc. (BHC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.20 million shares for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2018-11-06
- Bausch Health Companies Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-09-30 was 4.20M shares.
- Bausch Health Companies Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-06-30 was 3.20M shares, a 146.15% increase year-over-year.
- Bausch Health Companies Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-03-31 was 2.50M shares.
- Bausch Health Companies Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-06-30 was 1.30M shares, a 68.29% decline year-over-year.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|---|
| 2018-09-30 | 4.20M shares 10-Q · filed 2018-11-06 | 3.40M shares 10-Q · filed 2018-11-06 | |
| 2018-06-30 | 3.20M shares 10-Q · filed 2018-08-07 | 2.90M shares 10-Q · filed 2018-08-07 | |
| 2018-03-31 | 2.50M shares 10-Q · filed 2018-05-08 | ||
| 2017-06-30 | 1.30M shares 10-Q · filed 2018-08-07 | ||
| 2016-09-30 | 800.00K shares 10-Q · filed 2017-11-07 | 3.40M shares 10-Q · filed 2017-11-07 | |
| 2016-06-30 | 4.10M shares 10-Q · filed 2017-08-08 | 4.80M shares 10-Q · filed 2017-08-08 | |
| 2016-03-31 | 5.40M shares 10-Q · filed 2017-05-09 | ||
| 2011-09-30 | 285.00K shares 10-Q · filed 2011-11-04 | 259.00K shares 10-Q · filed 2011-11-04 | |
| 2011-06-30 | 178.00K shares 10-Q · filed 2011-08-08 | 178.00K shares 10-Q · filed 2011-08-08 | |
| 2010-09-30 | 1.02M shares 10-Q · filed 2011-11-04 | 1.79M shares 10-Q · filed 2011-11-04 | |
| 2010-06-30 | 2.17M shares 10-Q · filed 2011-08-08 | 2.18M shares 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |